July 31 - The U.S. National Institutes of Health said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer'sThe studies are designed to evaluate multiple therapies, where the first part of trial will test a longer dosing regimen of the antiviral COVID-19 drug Paxlovid to see if it improves long COVID symptoms.
The complex medical condition involves more than 200 symptoms ranging from exhaustion and cognitive impairment to pain, fever and heart palpitations that can last for months and even years following a COVID-19 infection.It will use medical treatments like a web-based brain training program called BrainHQ by San Franscisco-based private company Posit Science Corp and Soterix Medical Inc's device that uses a small electric current to stimulate brain activity, the health agency added.
Additional clinical trials are expected to be launched to test not less than seven more treatments, it said.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WashTimes - 🏆 235. / 63 Read more »